2019 EHE Summit
The 2019 EHE Summit created opportunities for collaborations within and across EHE pillar projects. The goals of this summit are to learn about aims and activities of EHE projects, initiate a shared vocabulary of IS terminology and methodology to enable collaborative communication, begin to identify opportunities for coordination across EHE projects and onboard teams to services provided by ISCI.
2019 EHE Summit – Speaker Bios
Day 1
Harold Phillips, Department of Health and Human Services
Harold J. Phillips works in the Office of HIV/AIDS and Infectious Disease Policy (OIDP), Office of Assistant Secretary for Health at the U.S. Department of Health and Human Services as the Senior HIV Advisor and Chief Operating Officer of the EHE Initiative. In this position, he oversees the coordination of the initiative’s activities, ensuring that all U.S. Department of Health and Human Services operating divisions are collaborating and communicating as they work to support jurisdictions in their plans to End the HIV Epidemic. Prior to joining OIDP, he was at the Health Resources and Services Administration’s HIV/AIDS Bureau where he served as Director of the Office of HIV/AIDS Training and Capacity Development; Deputy Director of the Ryan White Part B and AIDS Drug Assistance Programs, and served on the CDC/HRSA AIDS Advisory Committee from 2003 – 2010.
Carl Dieffenbach, National Institute of Allergy and Infectious Diseases
Carl W. Dieffenbach serves as Director of the Division of AIDS (DAIDS) where he oversees a global HIV/AIDS research portfolio and is responsible for planning, implementing, managing, and evaluating divisional programs. He received his bachelor’s degree in biochemistry from the University of Maryland and his Ph.D. in biophysics from The John Hopkins University. Dr. Dieffenbach played a key role in restructuring the DAIDS-supported clinical trials research networks and has actively fostered collaboration and partnerships with other federal agencies, international research organizations, professional societies, foundations, community advocacy groups, and industry.
Stacy Carrington-Lawrence, National Institutes of Health Office of AIDS Research Stacy Carrington-Lawrence, Ph.D., oversees the Develop Next-Generation HIV Therapies and Cross-Cutting Areas priorities of the NIH Office of AIDS Research. She also serves as the executive secretary for the NIH AIDS Executive Committee, composed of senior representatives from more than 20 Institutes, Centers, and Offices with HIV research in their portfolios, and responsible for helping to set the priorities and agenda for NIH research related to HIV and AIDS. Dr. Carrington-Lawrence completed a postdoctoral fellowship at the National Cancer Institute and then served in the NIH Office of Science Policy, where she worked on public private partnerships.
Christopher Gordon, National Institute of Mental Health
Dr. Christopher Gordon is the Chief of the HIV Treatment and Translational Science Branch at the Division of AIDS Research at the National Institute of Mental Health (NIMH) where he is responsible for development of new programmatic foci and initiatives, administration of currently funded research, and building scientific collaborations among other institutes, agencies, and community/clinical sites. Dr. Gordon coordinates the Division of AIDS Research activities
in Dissemination and Implementation research and is a member of the HIV Prevention Trials Network Behavioral Science Working Group, the NIH Centers for AIDS Research program steering committee, and the NIH Behavioral and Social Sciences Research Coordinating Committee. Dr. Gordon has published work on HIV prevention among those with mental disorders, prevention for persons living with HIV, and HIV treatment adherence.
Antigone Dempsey, Health Resources & Services Administration
Ms. Dempsey is the Division Director for Policy and Data at the Health Resources and Services Administration’s HIV/AIDS Bureau. She has dedicated her 29 year career to moving HIV prevention, care, support, and treatment services forward for all vulnerable populations. Prior to this position, Ms. Dempsey worked closely with many federal partners including the Substance Abuse and Mental Health Administration, and Centers for Disease Control and Prevention to provide organizational leadership, expert facilitation, training, technical assistance, strategic planning, policy development and systems change to address HIV, viral hepatitis, and substance abuse issues.
David Purcell, JD, PhD, CDC Centers for Disease Control and Prevention Dr. Purcell is the Deputy Director for Behavioral and Social Science for the Division of HIV/AIDS Prevention (DHAP), Centers for Disease Control and Prevention (CDC). He oversees four branches that focus on behavioral research and implementation science, prevention communications, program evaluation, and statistics, data management, and cost/resource allocation modeling. He received a BA in psychology and economics from Vanderbilt University, a JD from the University of Michigan Law School, and a PhD in clinical psychology from Emory University.
JD Smith, Northwestern Center for Prevention Implementation Methodology Dr. Smith is Associate Professor in the Department of Psychiatry and Behavioral Sciences Northwestern University Feinberg School of Medicine. His research focuses on the development of implementation science methods to translate evidence-based interventions to real-world service systems of care. He is Associate Director of the NIDA-funded Center for Prevention Implementation Methodology for Drug Abuse and HIV; is Co-Director of the Program in Dissemination and Implementation Science in Northwestern University’s Clinical and Translational Science Institute (NUCATS); and Chairs the Implementation Science Working Group of NCI’s IMPACT Research Consortium. He is a Fellow of the NIMH-funded Implementation Research Institute, and faculty of the NIH Training Institute in Dissemination and Implementation Research in Health (TIDIRH).
OUTCOMES
Russell Glasgow, University of Colorado
Russell E. Glasgow, Ph.D., Deputy Director for Implementation Science at the U. S. National Cancer Institute, is a behavioral scientist who has worked on many transdisciplinary research questions including worksite health promotion, primary care-based interventions, and community-based prevention programs involving community health centers and Native American tribes. He has researched target behaviors ranging from smoking prevention and cessation to chronic illness management, patient-provider communication, use of interactive technologies in health care, quality improvement and guidelines adherence. His more recent work has focused on public health issues of enhancing the reach and adoption of evidence-based programs, using the RE-AIM planning and evaluation model (www.re-aim.org).
Sarit Golub, Hunter College
Dr. Golub is Professor of Psychology at Hunter College and the CUNY Graduate Center. She is a Social Psychologist with training and experience in public health. Dr. Golub directs the Hunter HIV/AIDS Research Team (HART), which conducts collaborative, community-based research focusing on gender, sexuality, and HIV. Her research applies social cognitive theories to the study of health behavior, with a focus on sexual risk-taking and adherence. Dr. Golub’s NIH funded research applies findings across disciplines (including social psychology, behavioral economics and decision sciences) to inform new approaches to HIV prevention and care. She collaborates with community-based organizations throughout New York to translate study findings into prevention and care for vulnerable populations.
DETERMINANTS
Wynne Norton, National Cancer Institute
Dr. Norton is a Program Director in Implementation Science in the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). Dr. Norton’s research interests include de-implementation of ineffective interventions across the cancer control continuum, evidence-based cancer care delivery, and pragmatic clinical trials in implementation science. She is also involved in training programs and serves as faculty and planning committee member for the NIH Training Institute for Dissemination and Implementation Research in Health (TIDIRH) and the NCI Training Institute for Dissemination and Implementation in Cancer (TIDIRC). Dr. Norton is on the editorial board of the journal Implementation Science.
Greg Rebchook, University of California San Francisco
Dr. Rebchook is the Co-director of the CAPS Technology and Information Exchange Core and has been working in the HIV prevention field since 1987. Currently, he is the Principal Investigator of a CDC-funded grant to provide capacity building assistance to community-based
organizations, and is the Principal Investigator on a federally-funded HRSA SPNS project to evaluate and provide technical assistance to nine sites across the US who are developing innovative interventions to successfully engage HIV+ transgender women of color into HIV care. His current research also focuses on HIV prevention and engagement in care among young gay/bisexual/and other men who have sex with men (MSM), especially with young African American men.
Day 2
LISTENING SESSION
Maureen Goodenow, National Institutes of Health Office of AIDS Research
Maureen M. Goodenow, Ph.D., is Associate Director for AIDS Research at the National Institutes of Health (NIH) and Director of the NIH Office of AIDS Research (OAR) where she leads the OAR in coordinating the HIV/AIDS research agenda across the NIH. Before her tenure at OAR, Dr. Goodenow was involved in international AIDS efforts as the Acting Director of the Office for Research and Science within the U.S. Department of State, Office of the U.S. Global AIDS Coordinator and Office of Global Health Diplomacy. She oversaw combination prevention trials funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Prior to her government service, Dr. Goodenow was a professor of pathology, immunology, and laboratory medicine at the University of Florida where she held the Stephany W. Holloway University Endowed Chair for AIDS Research.
Dianne Rausch, Ph.D., the director of NIMH’s Division of AIDS Research Dr. Dianne Rausch is the Director of the Division of AIDS Research at the National Institute of Mental Health, part of the National Institutes of Health. In this role, she manages a research portfolio that encompasses a broad range of studies with the overarching goals of reducing the incidence of HIV/AIDS worldwide and decreasing the burden of living with HIV/AIDS. To this end, the Division supports research that includes basic and clinical neuroscience to better understand and alleviate the consequences of HIV infection of the central nervous system (CNS), and basic and applied behavioral science to prevent new HIV infections and limit morbidity and mortality among those infected. The Division places a high priority on interdisciplinary research across multiple populations, including racial and ethnic minorities, over the lifespan.
PROCESS MODELS
Lisa Saldana, Oregon Social Learning Center
Dr. Lisa Saldana is with the Oregon Social Learning Center. She received her doctorate in Clinical Psychology from the University of Missouri-Columbia with a research and clinical
emphasis in child maltreatment and evidence-based practice (EBP). Lisa currently is the PI of a number of federally funded projects related to implementation in child serving systems. Building on her previous work with the Stages of Implementation Completion (SIC), she and the SIC team are extending the SIC into the Sustainment Phase of the implementation process. Lisa and the SIC team have also developed the Cost of Implementing New Strategies (COINS) tool for assessing implementation costs across the three phases of implementation.
Sylvie Naar, Florida State University
Dr. Sylvie Naar is Director of Florida State’s Center for Translational Behavioral Research, a campus-wide center on behavioral health. Dr. Naar is a Distinguished Endowed Professor in Behavioral Health in the FSU‘s Department of Behavioral Sciences and Social Medicine. She is an expert in behavioral interventions to reduce health disparities in youth including both T1 behavioral translation research (basic behavioral science to intervention development) and T2 translation (efficacy to implementation). She has experience in multi-site evaluation studies of complex, multi-level interventions for the National Institutes of Health, Centers for Disease Control, and the Health Resources and Service Administration.
STUDY DESIGNS
Hendricks Brown. Northwestern University
Dr. C. Hendricks Brown is Professor in the Departments of Psychiatry and Behavioral Sciences, Preventive Medicine, and Medical Social Sciences in the Northwestern University Feinberg School of Medicine. He directs the NIDA funded Center for Prevention Implementation Methodology (Ce-PIM) for Drug Abuse and HIV. His research focuses on developing systems science for characterizing, modeling, and testing implementation strategies to scale up single evidence-based interventions, as well as suites of such interventions that can be selected by communities, especially those with health disparities. He has directed multiple reviews of interventions and developed systems for capturing various dimensions of scientific evidence as well as implementation factors that facilitate or impede program delivery.
STRATEGIES and MECHAMISMS
Byron Powell, Washington University
Dr. Byron Powell is an Assistant Professor at the Institute for Public Health at Washington University in St. Louis. His work has focused on efforts to improve implementation research and practice. Nationally, he is Co-Chair of the Implementation Special Interest Group of the Society for Social Work and Research, and the New Investigator Network of Expertise of the Society for Implementation Research Collaboration. His research focuses on efforts to improve the quality of behavioral health and social services, specifically around: identifying contextual barriers and facilitators to implementing evidence-based practices in routine care; identifying and assessing the
effectiveness of implementation strategies; and developing methods for designing and tailoring implementation strategies, and 4) advancing implementation research methods.